Research / STE / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-006055 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
126.88% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.60% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.93% · OPTIONAL · VALID
Revenue growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.17% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
45.01% · OPTIONAL · VALID
Gross margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
43.81% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.26% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.97% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.05% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 129.93%
Current 126.88%
Delta -3.04% Capex Intensity Increased
Previous 5.92%
Current 6.60%
Delta 0.67% Cash Generation Increased
Previous 19.71%
Current 19.93%
Delta 0.22% Growth Decreased
Previous 9.89%
Current 9.17%
Delta -0.72% Inventory Pressure Decreased
Previous 45.09%
Current 45.01%
Delta -0.08% Margin Decreased
Previous 44.23%
Current 43.81%
Delta -0.42% Profitability Increased
Previous 18.20%
Current 18.26%
Delta 0.06% R And D Intensity Increased
Previous 1.93%
Current 1.97%
Delta 0.04% Sbc Intensity Decreased
Previous 1.45%
Current 1.05%
Delta -0.40% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.